Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 3/20 | 0.47 |
| ▸ | GBA1 | P04062 | 3/20 | 0.42 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.41 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.38 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.35 |
| ▸ | CDK4 | P11802 | 1/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5490361 | 1.00 | PIK3CA (0.47) | PIK3CAGBA1PDE3BPDE3APDE10A | |
| SCHEMBL5488400 | 0.90 | PIK3CA (0.45) | PIK3CAGBA1PDE3BPDE3APDE10A | |
| SCHEMBL5488392 | 0.90 | PIK3CA (0.45) | PIK3CAGBA1PDE3BPDE3APDE10A | |
| SCHEMBL5024455 | 0.85 | PIK3CA (0.41) | PIK3CAPDE3BPDE3APDE10APARP14 | |
| SCHEMBL5024456 | 0.85 | PIK3CA (0.41) | PIK3CAPDE3BPDE3APDE10APARP14 | |
| SCHEMBL5492423 | 0.83 | PIK3CA (0.56) | PIK3CAPARP14KIT | |
| SCHEMBL5486950 | 0.76 | HRH4 (0.44) | PDE3BPDE3APDE10AENPP1MAOB | |
| SCHEMBL5486946 | 0.76 | HRH4 (0.44) | PDE3BPDE3APDE10AENPP1MAOB | |
| Hydrochloric Acid SCHEMBL5490207 | 0.75 | HRH4 (0.44) | PDE3BPDE3APDE10AENPP1MAOB | |
| Hydrochloric Acid SCHEMBL5490214 | 0.75 | HRH4 (0.44) | PDE3BPDE3APDE10AENPP1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205309-B2 | Quinazoline derivatives | HOFFMANN-LA ROCHE INC. (US) | 2007-04-17 | — | — | US | claimed |
| US-20040029901-A1 | Quinazoline derivatives | HOFFMANN-LA ROCHE INC. | 2004-02-12 | — | — | US | claimed |
| US-7205309-B2 | Quinazoline derivatives | HOFFMANN-LA ROCHE INC. (US) | 2007-04-17 | — | — | US | disclosed |
| US-20040029901-A1 | Quinazoline derivatives | HOFFMANN-LA ROCHE INC. | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029901-A1 | Quinazoline derivatives | GPR119, NQO2, CYP7A1 | PIK3CA 2625/4885GBA1 688/4885PDE3B 298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.